Enlaza Therapeutics, Inc.
Pharmaceutical company · La Jolla, California, United States
Enlaza Therapeutics, Inc. is a pharmaceutical company headquartered in La Jolla, California, United States. Its earliest recorded incorporation is in 2020. It has reported private securities offerings to the US SEC, most recently $15 million sold in a notice filed in 2025.
Enlaza Therapeutics at a glance
What does Enlaza Therapeutics do?
Private fundraising reported to the SEC
8 Form D notices; the most recent reported $15 million sold (2025).
Frequently asked questions about Enlaza Therapeutics
Where is Enlaza Therapeutics headquartered?
Enlaza Therapeutics, Inc. is headquartered in La Jolla, California, United States.
What does Enlaza Therapeutics do?
Enlaza Therapeutics, Inc. is a pharmaceutical company.
When was Enlaza Therapeutics founded?
The earliest incorporation on record for Enlaza Therapeutics, Inc. is in 2020, according to public company registers.
Similar companies
- CalciMedica, Inc.La Jolla, California, United States
- Ensysce Biosciences, Inc.La Jolla, California, United States
- Boundless Bio, Inc.La Jolla, California, United States
- Longboard Pharmaceuticals, Inc.La Jolla, California, United States
- Auspex Pharmaceuticals, Inc.La Jolla, California, United States
- Sophiris Bio Inc.La Jolla, California, United States
- Orexigen Therapeutics, Inc.La Jolla, California, United States
- Ambrx IncLa Jolla, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences